Kirk Rousset, MD
Obstetrics & Gynecology · Baton Rouge, LANPI 1407832926
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AbbVie at 26.8% of the total. Reporting peaked in 2022 at $166 and has fallen 89.8% since, to $17 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in LA, where the typical reported total is $1,022.
Across 18 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$90
- Gynesonics, Inc.$62
- Duchesnay USA Incorporated$48
- Minerva Surgical, Inc$38
- Amgen$28
- Therapeuticsmd, Inc.$25
- plus $46 from 3 others
What the payments were for
- Food & beverage$338100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $90 |
| Gynesonics, Inc. | 1 | $62 |
| Duchesnay USA Incorporated | 3 | $48 |
| Minerva Surgical, Inc | 3 | $38 |
| Amgen | 2 | $28 |
| Therapeuticsmd, Inc. | 1 | $25 |
| Millicent US Inc | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $14 |
How this compares
$338 in reported general payments places this provider in the 25th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 11 | $5,599 |
| Estradiol | 236 | $3,389 |
| PremproEstrogen,con/M-Progest Acet | 13 | $2,967 |
| DottiEstradiol | 24 | $2,273 |
| ValacyclovirValacyclovir Hcl | 33 | $921 |
| Estradiol (Twice Weekly)Estradiol | 20 | $637 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 14 | $316 |
| Ibandronate Sodium | 21 | $286 |
| Medroxyprogesterone Acetate | 17 | $207 |
| Fluconazole | 24 | $107 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Baton Rouge
- Thomas PayneBaton Rouge$84K
- Joseph DiggsBaton Rouge$22K
- Taylar Childress-MckeithenBaton Rouge$9K
- Nicole ChauvinBaton Rouge$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
- Earl PeeperNew Orleans$95K
- Catherine VanderloosShreveport$55K
- George MorrisNew Orleans$34K
- Russell PhelpsLafayette$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.